Replies to post #41473 on Arrayit Corporation (ARYC)

[PennyStock Alert]

Top Reasons To Invest in Arrayit Corporation:
ARYC
Trading at .0054!!! and headquartered in Silicon Valley. Arrayit Corporation (Arrayit) is a leading edge developer, manufacturer and marketer of next-generation life science tools and integrated systems for the large-scale analysis of genetic variation, biological function and diagnostics. Using Arrayit’s proprietary technologies, the Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping, gene expression and protein analysis markets, and the Company expects to enter the market for molecular diagnostics.

Arrayit has earned respect as a leader in the healthcare and life sciences industries with its proven expertise in three key areas: the development and support of microarray tools and components, custom printing and analysis of microarrays for research, and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states.
As a result, Arrayit has provided tools and services to thousands of the leading genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies worldwide.
The Company’s patented tools and trade secrets provide researchers around the world with the performance, throughput, cost effectiveness and flexibility necessary to perform the billions of genetic tests needed to extract valuable medical information. The Company believes this information will enable researchers to correlate genetic variation and biological function, which will enhance drug discovery, drug development and clinical research, allowing diseases to be detected earlier and permitting better choices of drugs for individual patients.
Revenues last year of over $8 million !!

Sales reported at ~$10,000 every day
Arrayit receives new financing lead that could generate 6,000 x $100K = $600MM in Arrayit microarray platform sales http://arrayit.com
Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
ARYC also owns 40 million shares of AVDX. A value of ~$12 million
Arrayit and USDA Expanding Patent Protection for Food Safety Testing Worldwide http://www.arrayit.com/Arrayit_Corporation_ARYC_Corpo/Microarray_Media_-_Press/Arrayit_and_USDA_Expanding_Pat/arrayit_and_usda_expanding_patent_protection_for_food_safety_tes.html

Arrayit reports $400,000 microarray services inquiry from advanced pharmaceutical leader Cellceutix CTIX Beverly MA
(link: http://www.cellceutix.com)
cellceutix.com

Arrayit Corporation (ARYC) technology empowered scientists at the Scripps Institute to make an important medical breakthrough in diagnosing Alzheimer’s Disease. Scripps scientists used a scientific instrument known as an Arrayit NanoPrint Enterprise Level Microarrayer (shown here) to manufacture diagnostic microarray devices, which allowed researchers to identify unique protein biomarkers in the bloodstream of Alzheimer’s patients. This diagnostic test may help doctors better understand and treat the effects of this debilitating neurodegenerative disease.
Arrayit Corporation Debuts Major New Genomics and Proteomics Products in 2015/2016 Catalog
Arrayit Corporation and Vivos Team Up on Global Genome Vault
Arrayit customers in Tel Aviv Israel use Arrayit microarray technology to publish bioprosthetic heart valve advance http://onlinelibrary.wiley.com/doi/10.1111/xen.12260/full
Arrayit customers at Chemical Engineering Korea use Arrayit microarray platform to publish cholera detection advance
Arrayit reports microarray technology inquiry from next generation sequencing leader Direct Genomics Guangdong China
Arrayit selected for the 2016 Best of Sunnyvale Awards for a Biotechnology Company by Sunnyvale Business Recognition
Arrayit reports microarray technology sale to $233.2MM life sciences leader Fluidigm Nasdaq:FLDM Markham ON Canada
Arrayit reports microarray tech inquiry from $56.7B pharmaceutical giant Abbott Laboratories NYSE:ABT Carlsbad CA
Arrayit reports microarray technology sale to $56.6B life sciences juggernaut Thermo Fisher NYSE:TMO Pittsburgh PA
Arrayit reports microarray technology inquiry from top RNA hybridization leaders Advanced Cell Diagnostics Newark CA
Arrayit reports microarray reagents sale to advanced molecular diagnostics distributor AH Diagnostics Aarhus Arrayit reports microarray technology sale to top EU life sciences distributor Novusci Bedfordshire United Kingdom
Arrayit quotes $7.1 million variation identification platform (VIP) genotyping package to top clinical testing laboratory in Southeast Asia
Arrayit reports $393,294 sales and marketing lead from a top wellness and clinical testing company in European Union
Arrayit reports $7,500 microarray technology sale to top research scientists Oklahoma State University Stillwater OK
Arrayit's microarray manufacturing technology enables these new molecular diagnostic devices
Arrayit reports $20,000 specialty chemical sale to 100% owned chemical trading subsidiary TeleChem International Inc http://www.telecheminternational.com

Arrayit customers from Arizona State use Arrayit microarray technology to publish adult stem cell therapy advance http://www.sciencedirect.com/science/article/pii/S1873506115000598
Can an antibody microarray made with Arrayit technology replace in-situ hybs in HER2 breast cancer diagnostics?...
Arrayit reports $15K microarray sale to top medical Stephenson Cancer Center Oklahoma City http://stephensoncancercenter.org
Arrayit quotes $179,430 microarrays to biomedical leader Progenie Molecular Valencia España http://www.progenie-molecular.com
Arrayit quotes $51,680 microarrays to top leader De La Salle University Manila Philippines http://www.dlsu.edu.ph
Arrayit quotes $102,240 microarray platform to venture think tank Leading Technology Group http://www.leadingtechnology.co
Arrayit quotes $38,485 microarray platform to top Korean distributor Daemyung Science Seoul http://www.dm4you.com
Arrayit completes conference call on huge DNA testing opportunity in massive market in India http://arrayit.com/Services/SNP_Genotyping/snp_genotyping.html
Arrayit reports DNA testing inquiry from top agency in India. Market penetration of 0.1% would produce $48M revenues http://arrayit.com/Services/SNP_Genotyping/snp_genotyping.html
Arrayit quotes $235,000 microarray instruments to top lab University Ottawa Ontario Canada http://www.uottawa.ca
Arrayit reports microarray sale to advanced technology leaders Waki Company Tokyo Japan http://waki-bg.jp
Arrayit reports microarray sale to automated molecular testing leader AutoGenomics Vista CA http://www.autogenomics.com
Arrayit reports microarray sale to life sciences European Biotech Network Dolembreux Belgium http://www.euro-bio-net.com
Arrayit reports microarray sale to top medical researcher at $13.4B endowed MIT Cambridge MA http://web.mit.edu
Arrayit expands marketing on $100K+ TissueMax™ Automated and Personal Tissue Microarrayers
Arrayit reports $400,000 microarray instruments inquiry from top European Union distributor
Arrayit invited to appear on Business Television BTV hosted by broadcast partner Bloomberg http://www.b-tv.com
Arrayit $17.7MM OvaDx® spin-off and 6,000 diagnostic test pipeline possibility emphasizes the $17.7MM x 6,000 = $106B ARYC market potential.
Arrayit reports $9K chemical sale in specialty trading subsidiary TeleChem International Inc http://www.telecheminternational.com
Arrayit reports $100K microarray inquiry Al Rayyan International Science Center Amman Jordan
Arrayit products featured in 5,000+ scientific publications. https://scholar.google.com/scholar?hl=en&lr=&q=arrayit+microarray
Investors - Celebrity Spokesperson - Khrystyne Haje
Link to their products: http://www.arrayit.com/Products/products.html
https://twitter.com/arrayit
Facebook https://www.facebook.com/Arrayit
Yahoo http://finance.yahoo.com/quote/ARYC?ltr=1
http://arrayit.blogspot.com/

[PennyStock Alert]

Arrayit has earned respect as a leader in the health care and life sciences industries with its proven expertise in three key areas: the development and support of microarray tools and components, custom printing and analysis of microarrays for research, and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. As a result, Arrayit has provided tools and services to thousands of the leading genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies worldwide.